Oncology Topic Homepage

Learning Zones

,CLL Knowledge Centre and CME

The CLL Knowledge Centre and CME provide healthcare professionals with important information to aid the treatment and management of patients with the disease. Content is arranged within four main areas: Disease awareness, Events, Resources and CME.

Healthcare professionals will find sections on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment, management, an upcoming events calendar and useful external links.

The CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ allows you to read case studies and improve your knowledge of CLL by answering quiz questions based on a variety of scenarios. This module has been EACCME-accredited and is worth 1 European CME credit. There is no cost to complete this educational activity.

,Prostate Cancer Learning Hub

Prostate cancer is the third most frequently diagnosed cancer in Europe and the most common cancer among European men,1 making it a major cause of morbidity. Risk factors for prostate cancer include, increasing age, genetic susceptibility, glucose intolerance and environmental factors.2

The Prostate Cancer Learning Hub has been designed with the busy healthcare professional in mind. The resource conveniently organises a range of up-to-date education content, reference materials and decision support tools, all focussing on prostate cancer.

The disease awareness section provides you with access to a Prostate Cancer Knowledge Centre, which has been developed to provide you with easy to digest best practice guidance for the treatment and management of patients with prostate cancer. In addition access to editorials of key journal publications, an events calendar, video channel, patient materials and interactive healthcare professionals tools are also available.

References

  1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013;49:1374-1403. EUCAN fact sheet. Estimated incidence, mortality & prevalence, 2012.
  2. Tewari R, Rajender S, Natu SM et al. Diet, obesity, and prostate health: are we missing the link? J Androl 2012;33:763-776.

     

Clinical Case Studies

Smoking Cessation

Respiratory Medicine & Allergy: Lung Cancer

Suma Kumar, Guy's and St Thomas' NHS Foundation Trust, London, UK
Richard Leach, Consultant Respiratory Physicians, Guy's and St Thomas' NHS Foundation Trust, London, UK

Case History
The wife and daughter of a patient you are treating for lung cancer are concerned about their risk of developing cancer. The wife is an ex-smoker having stopped six months ago.

Mediastinal Mass: Bronchogenic Cyst

Respiratory Medicine & Allergy: Lung Cancer

Elizabeth Hadley, Consultant Respiratory and General Physician, Barking, Havering and Redbridge Hospitals University NHS Trust, London, UK

Case History
A 24-year-old woman was seen in the chest clinic with an eight-week history of cough with occasional sputum, fever and malaise. She also described an occasional nagging pain under her sternum and palpitations.

Latest News

Blog

Overdiagnosis is the diagnosis of disease that will cause neither morbidity nor mortality during a patient’s lifetime. Doctors are trained to listen, examine, test, diagnose and treat patients, but we are not warned of the possible dangers of “diseases”, the diagnosis of which will not benefit the patient and may also lead to harm. I would argue the Hippocratic oath, in particular “Primum non nocere” (first, do no harm) should be at the forefront of every clinician’s mind when seeing patients. 

In this blog, I shall outline precisely what overdiagnosis is, why it is important and why we all need to take note of this crisis in healthcare. 

Medical Videos

An Overview of Pancreatic NET and the Available Treatments
An Overview of Pancreatic NET and the Available Treatments
Surviving Advanced Breast Cancer
Surviving Advanced Breast Cancer
New Developments in the Treatment of Breast Cancer
New Developments in the Treatment of Breast Cancer
In the podcast, Dr. Crawford describes current and upcoming options available to urologists for treating this group of patients.
In the podcast, Dr. Crawford describes current and upcoming options available to urologists for treating this group of patients.
Eribulin Trial Success
Eribulin Trial Success
Metastatic Breast Cancer - A Patient's View of Various Treatments Including Eribulin
Metastatic Breast Cancer - A Patient's View of Various Treatments Including Eribulin
An Animation Explaining the Development of Lymphoma
An Animation Explaining the Development of Lymphoma
HPV Vaccine
HPV Vaccine
Cancer Vaccines- Dr. Kelvin Lee
Cancer Vaccines- Dr. Kelvin Lee

Recent Drug Updates

Medical Journal Abstracts on Oncology

Imatinib: a breakthrough of targeted therapy in cancer.

-98 days ago -  Imatinib: a breakthrough of targeted therapy in cancer.

Deregulated protein tyrosine kinase activity is central to the pathogenesis of human cancers. Targeted therapy in the form of selective tyrosine kinase inhibitors (TKIs) has transformed the approach ...

Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?

-14 days ago -  Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?

Anti-EGFR therapy and antiangiogenic therapies are used alone or in combination with chemotherapies to improve survival in metastatic colorectal cancer. However, it is unknown whether pretreatment ...

Medical Images

Hypersensitivity Pneumonitis
Hypersensitivity Pneumonitis
Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer (NSCLC)
Amiodarone Pulmonary Toxicity
Amiodarone Pulmonary Toxicity
Small Cell Lung Cancer (SCLC)
Small Cell Lung Cancer (SCLC)
Sarcoidosis - chest radiograph
Sarcoidosis - chest radiograph
Pulmonary nodule
Pulmonary nodule
Hematoxylin and eosin stain
Hematoxylin and eosin stain
Bronchogenic cyst
Bronchogenic cyst
Sarcoidosis - radiograph showing interstitial shadowing
Sarcoidosis - radiograph showing interstitial shadowing

Clinical Guidelines

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Aug 2015

Chronic lymphocytic leukaemia is the most common leukaemia in the Western world and generally..

... affects older populations. These updated ESMO Clinical Practice Guidelines present the latest information on CLL including the diagnosis and molecular biology of CLL and treatment strategies for early and advanced disease.

Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Aug 2015

Diffuse large B-cell lymphoma is relatively common and represents 30%–58% of..

... non-Hodgkin’s lymphomas. The updated ESMO Clinical Practice Guidelines provide information on the current management of diffuse large B-cell lymphoma including recommendations for screening and diagnosis, staging and risk assessment and stage-matched therapeutic strategies including specific recommendations for young and elderly, low-to-high risk subgroups.

Online CME

Treatment Optimisation in Chronic Lymphocytic Leukaemia

A new CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been added to the CLL Knowledge Centre on epgonline.org. Read case studies and improve your knowledge of CLL by...

Challenges and Best Practices in the Use of Radionuclide Therapy in mCRPC

This activity is intended for radiation oncologists, medical oncologists, nuclear medicine specialists, urologists, and other clinicians who comprise the team of interprofessionals caring for men with metastatic castration-resistant prostate cancer....

Managing the side effects of treatment for prostate cancer - in association with Prostate Cancer UK

"After you have completed this module you should: Know what the acute and chronic side effects of treatment for prostate cancer are Understand why side effects occur Know how to...

Clinical Trials

Oral THU-Decitabine + Nivolumab for Advanced Non-Small Cell Lung Cancer

-141 days ago

This study looks at the effect of three drugs on lung cancer tumors. This study includes two groups of patients randomized to either Nivolumab, which is the standard of care for this lung cancer, or ...

Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone

-111 days ago

The purpose of this trial is to test if the combination of enzalutamide and metformin in patients with castration resistant prostate cancer progressing on androgen deprivation therapy is more ...

Back to top